John Klassen

About

B.Sc., Queen's University

Ph.D., University of Alberta

Research

Research in the Klassen Lab focuses on enabling technologies for functional glycomics and disease diagnostics. We are developing analytical tools, based on state-of-the-art mass spectrometry, to accelerate the discovery and characterization of biologically-relevant glycan interactions. We exploit this knowledge to gain a greater understanding of the role that glycans play in human health and disease and aid in the development of new therapeutics. We are developing powerful new tools to characterize the activity and substrate specificity of carbohydrate-active enzymes (CAZymes) and translate these insights into new diagnostics for diseases such as cancer and neurodegeneration. We are also developing mass spectrometry-based tissue imaging tools to uncover the complex relationships between diseases and glycosylation.

Please visit the Klassen Group Website for more information about our research and openings in the group: http://klassengroup.ca/